TP53 and glioma: The significant co-occurrence of IDH1 hotspot mutation and TP53 alteration in glioma was in accordance with the consistently high frequencies found across various histological subtypes, including glioblastoma, from both TCGA_PanCancer and MSK_Impact (Table 5).